J Immunol
J Immunol
Supplementary
Material
References
Subscriptions
Permissions
Email Alerts
http://www.jimmunol.org/content/suppl/2014/04/11/jimmunol.130269
2.DCSupplemental.html
This article cites 40 articles, 18 of which you can access for free at:
http://www.jimmunol.org/content/192/10/4709.full#ref-list-1
Information about subscribing to The Journal of Immunology is online at:
http://jimmunol.org/subscriptions
Submit copyright permission requests at:
http://www.aai.org/ji/copyright.html
Receive free email-alerts when new articles cite this article. Sign up at:
http://jimmunol.org/cgi/alerts/etoc
*Inflammation Program, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Veterans Administration Medical Center, Iowa City, IA 52240;
most bacterial infections, including those due to S. aureus (reviewed in Ref. 2). In general, PMN readily phagocytose bacteria
and use a variety of agents stored in granules and PMN-generated
HOCl to kill ingested microbes (3, 4). However, in the case of
S. aureus, 1550% of the initial ingested inoculum survives within
the PMN phagosome (57), and PMN containing viable S. aureus
initially exhibit some features consistent with accelerated apoptosis but 6 h following phagocytosis abruptly undergo lysis (7).
How the presence of viable bacteria within PMN directs the fate
of the phagocyte and the extent to which the induced changes in
PMN contribute to disease pathogenesis are unknown. Generally,
macrophages ingest spent or apoptotic PMN in a process termed
efferocytosis, thereby clearing damaged or dead host cells and
microbes to restore tissue to an uninflamed state. The interaction
of human macrophages and PMN harboring viable S. aureus has
not been explored.
Reasoning that events early in the interaction between innate
immune cells and invading S. aureus likely influence the subsequent course of disease, we examined the roles played by PMN
harboring viable CA-MRSA strain USA300 (PMN-SA) and macrophages in controlling or contributing to infection. Using human
PMN and a pulsed fieldtype USA300 strain, we demonstrate that
PMN-SA initially exhibited signs of apoptosis, including surface
exposure of phosphatidylserine (PS) and mitochondrial membrane
depolarization, but failed to activate caspase-3, -8, -9, and -2.
PMN-SA increased expression of the dont eat me signal CD47,
resulting in decreased uptake by macrophages and a secondary
skewing of the cytokine profile. Cytoplasmic levels of proliferating cell nuclear Ag (PCNA) were sustained in PMN-SA and the
eventual lysis of PMN-SA was blocked by the receptor-interacting
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) pose a significant threat to human health. Polymorphonuclear leukocytes (PMN) are the first responders during staphylococcal infection, but 1550% of the initial ingested
inoculum survives within the PMN phagosome and likely contributes directly or indirectly to disease pathogenesis. We hypothesize
that surviving intracellular CA-MRSA undermine effective phagocyte-mediated defense by causing a decrease in macrophage
uptake of PMN containing viable S. aureus and by promoting PMN lysis. In support of this hypothesis, PMN harboring viable CAMRSA strain USA300 (PMN-SA) upregulated the dont eat me signal CD47, remained bound to the surface, and were
inefficiently ingested by macrophages. In addition, coculture with PMN-SA altered the macrophage phenotype. Compared to
macrophages fed USA300 alone, macrophages challenged with PMN-SA produced more IL-8 and less IL-1 receptor antagonist,
TNF-a, activated caspase-1, and IL-1b. Although they exhibited some features of apoptosis within 3 h following ingestion of
S. aureus, including phosphatidylserine exposure and mitochondrial membrane depolarization, PMN-SA had sustained levels of
proliferating cell nuclear Ag expression, absence of caspase activation, and underwent lysis within 6 h following phagocytosis.
PMN lysis was dependent on receptor-interacting protein 1, suggesting that PMN-SA underwent programmed necrosis or
necroptosis. These data are the first demonstration, to our knowledge, that bacteria can promote sustained expression of proliferating cell nuclear Ag and that human PMN undergo necroptosis. Together, these findings demonstrate that S. aureus surviving
within PMN undermine the innate immune response and may provide insight into the pathogenesis of S. aureus disease. The
Journal of Immunology, 2014, 192: 47094717.
4710
S. aureus culture
Assays were performed using the USA300 LAC wild-type strain as described previously (5). Nonpathogenic RN6390 were obtained from
Dr. Alex Horswill (Department of Microbiology, University of Iowa, Iowa
City, IA). To obtain a USA300 stain expressing superfolded GFP (sGFP),
a LAC-derivative strain that has been cured of the cryptic plasmid pUSA03
[AH1263 (8)] was transduced with plasmid pCM29 (9) and selected with
10 mg/ml chloramphenicol. The AH1263 strain was also used for the
Luminex and ELISA assays. All USA300 strains are referred throughout as
USA300 or SA. S. aureus strains were grown in tryptic soy broth overnight
at 37C with shaking at 180 rpm. Bacteria were then diluted (OD550 0.05)
in TBS containing 0.1% HSA and subcultured at 37C with shaking at
180 rpm until early-logarithmic phase (OD550 0.10.2). Bacteria were
then suspended in HBSS with divalent cations containing 20 mM HEPES
or RPMI 1640 medium containing 10 mM HEPES and opsonized with
human serum (10% pooled or 50% autologous serum) for use in the assay.
PMN isolation
PMN were isolated from normal healthy volunteers and purified from
venous blood (as described in Ref. 10). Written consent was obtained from
each volunteer in accordance with a protocol approved by the Institutional
Review Board for Human Subjects at the University of Iowa or the National Institute of Allergy and Infectious Diseases, National Institutes of
Health. Briefly, heparinized blood was collected and PMN were isolated
following sedimentation with 3% dextran, separation on Ficoll Hypaque
gradient, and hypotonic lysis of RBCs. PMN were then kept on ice in
HBSS without divalent cations or RPMI 1640 medium containing 10 mM
HEPES and counted. This technique resulted in 9399% PMN purity as
measured by staining with HEMA-3 and analysis by light microscopy or as
determined by flow cytometry.
All reagents were purchased from Fisher Scientific (Pittsburgh, PA) unless
otherwise indicated. Clinical grade dextran T500 (Pharmacosmos, Holbaek,
Denmark), Ficoll-Hypaque PLUS (GE Healthcare, Piscataway, NJ), sterile
endotoxin-free water, and 0.9% sterile endotoxin-free sodium chloride
(Baxter, Deerfield, IL) were used in neutrophil preparations. HEPES, HBSS
(with [HBSS++] and without divalent cations), and Dulbeccos PBS were
purchased from Mediatech (Manasssas, VA). A HEMA-3 staining kit was
obtained from Fisher Scientific, and 25% human serum albumin (HSA)
was purchased from Talecris Biotherapeutics (Raleigh, NC). Heparin was
purchased from APP Pharmaceuticals (Schaumburg, IL). Tryptic soy agar
and broth were obtained from BD Biosciences (San Jose, CA). Poly- Llysinecoated poly-prep slides, diphenyleneiodonium, and Nec-1 were purchased from Calbiochem/EMD Biosciences (La Jolla, CA) and SigmaAldrich (St. Louis, MO). RPMI 1640 was purchased from Lonza (Hopkinton,
MN). Hyclone FBS was purchased from Thermo Scientific (Waltham,
MA) and heat inactivated for 30 min at 56C. Annexin VFITC Apoptosis
Detection Kit and anti-human caspase-3 Ab were obtained from BioVision
(Mountain View, CA). JC-1 assay kit was purchased from Invitrogen
(Grand Island, NY). CellTrace Far Red DDAO-SE (CTFR; Invitrogen,
Grand Island, NY) was reconstituted to 2 mM in DMSO and stored at
220C. Anti-human CD15-PE and anti-human CD14-PE Cy5.5 (Beckman
Coulter, Fullerton, CA) were used for phagocytosis assays. Anti-human
CD47 and caspase inhibitor Q-VD-OPh were obtained from R&D Systems
(Minneapolis, MN), anti-human caspase-1 was obtained from Cell Signaling Technology (Danvers, MA), human Fc block was obtained from
eBioscience (San Diego, CA), anti-human PCNA (sc-56) was obtained
from Santa Cruz Biotechnology (Santa Cruz, CA), mouse antib-actin
and mouse anti-Fas (human, activating) were purchased from Millipore
(Temecula, CA), and a Cytotoxicity Detection KitPLUS was purchased
from Roche (Indianapolis, IN).
Immunoblot analyses
Cytotoxicity assays
For experiments using a caspase inhibitor, PMN were pretreated with or
without 40 mM Nec-1 and/or 10 mM Q-VD-OPh for 20 min prior to
challenge with USA300 at an MOI of 1:1. Alternatively, PMN were pretreated with 0, 10, 50, 100, 200, or 500 mM Nec-1, and USA300 was added
to assays at an MOI of 10:1 as indicated. Lactate dehydrogenase (LDH)
activity was measured from supernatants in duplicate wells 6 h following
phagocytosis as reported previously (7).
Statistical analyses
One-way ANOVA and Dunnett or Tukey posttests were used to calculate
statistical significance. Unless indicated otherwise, p values were obtained
from the posttests used to correct for multiple comparisons (*p , 0.05).
Results
PMN fed S. aureus differentially regulate eat me and dont
eat me signals
Despite efficient uptake by PMN, 1550% of the ingested inoculum of USA300 or RN6390 remained viable 180 min after phagocytosis, as judged by two independent measures of bacterial viability
(12) (Supplemental Fig. 1). Furthermore, PMN acquire many of
the morphologic signs of apoptosis early on, including exposure of
PS and nuclear condensation, when challenged with USA300 at an
MOI of 10:1 (7). PMN fed USA300 or RN6390 at an MOI of 1:1
exhibited greater Annexin V staining than did control cells, and
this Annexin V staining increased over time (Fig. 1A). Importantly,
the majority of Annexin V+ cells remained negative for PI during
this time (Fig. 1A), indicating that the SA-laden PMN remained
viable. Increasing the MOI to 5:1 resulted in a similar percentage
of Annexin V+ cells, but a greater percentage of cells positive for
FIGURE 1. PMN challenged with S. aureus upregulate dont eat me signal CD47. PMN were in buffer alone or fed USA300 or RN6390 at an MOI of
1:1 and monitored for 60180 min. Cells were stained for Annexin VFITC and PI to distinguish apoptotic and necrotic cells, respectively (A). Shown on
the left axis and connected by a solid line are Annexin V+ cells, and on the right axis and connected by a dashed line are Annexin V+PI+ cells. Symbols
represent the mean of at least five experiments 6 SEM (A). PMN were stained after 60 min with JC-1 dye to measure mitochondrial depolarization and
analyzed by flow cytometry. p values were determined using repeated measures one-way ANOVA and Dunnett posttest [(B) n = 5 6 SEM]. PMN were
isolated and either aged for 1824 h (Aged) or challenged with USA300 at an MOI of 1:1 for 60 min. Cells were stained for CD47 and analyzed by flow
cytometry. Shown is a representative of three experiments (C) and average MFI from the five individual experiments 6 SEM (D). p values were determined
using one-way ANOVA and Tukey posttest. *p , 0.05 versus PMN, #p , 0.05 versus Aged PMN.
For caspase-1 detection, macrophages were lysed (50 mM Tris-HCl [pH 8],
5 mM EDTA, 150 mM NaCl, and 1% Triton X-100 containing protease
inhibitor mixture of 0.5 mM benzamidine, 0.5 mM PMSF, 0.1 mg/ml
aprotinin, 0.1 mg/ml phosphoarmidone, 0.1 mg/ml tosyllysine chloromethylketone hydrochloride, 0.1 mg/ml tosylphenylalanyl chloromethyl ketone,
0.1 mg/ml 4-amidinophenylmethanesulfonyl fluoride, 0.1 mg/ml E-64,
0.05 mg/ml leupeptin, and 0.01 mg/ml pepstatin) at indicated time points,
proteins were resolved in a gradient SDS-PAGE gel, and transferred to
polyvinylidene difluoride membrane for immunoblotting. For caspase-3,
PCNA, and b-actin detection, PMN were lysed as previously described
(16). For immunoblotting, Fas stimulation was used as a positive control
for apoptosis using 500 ng/ml anti-Fas Ab. The following dilutions were
used for immunoblots: 1:1,000 anticaspase-1, 1:200 anticaspase-3, 1:200
anti-PCNA, and 1:20,000 antib-actin. The pixel intensity of bands in
immunoblots was measured using a phosphoimager (Typhoon 9410 Variable Mode Imager; GE Healthcare).
4711
4712
as PMN-SA ingested by macrophages, or as free S. aureus released from lysed PMN and ingested by macrophages. Overall, the
majority of CD14+ macrophages (50.2 6 17.9% at 60 min; n = 4)
associated with viable S. aureus that appeared to be distributed
in one of these three different populations (Fig. 2C). Most sGFPUSA300 were found within PMN bound extracellularly to macrophages, whereas 69% were in PMN that had been ingested by
macrophages, and only 2 to 3% were free within macrophages.
These data suggest that macrophages did not effectively ingest
PMN-SA and that USA300 did not efficiently exploit PMN as
a Trojan horse to gain entry into macrophages. The flow cytometry
results indicating that most PMN-SA were bound to the surface of
macrophages was confirmed by confocal microscopy (Supplemental
Fig. 2B).
To determine if soluble cues from PMN-SA inhibited the capacity of macrophages to mediate efferocytosis, we compared ingestion of Aged PMN by macrophages in the presence or absence
both Annexin V and PI (data not shown), suggesting that the PMN
plasma membrane was more readily compromised at an increased
bacterial MOI.
Accompanying the increased expression of PS on the surface
of cells, PMN fed USA300 or RN6390 exhibited greater loss of
mitochondrial membrane potential compared with that in unstimulated PMN, as measured by the fluorescent membrane potential
sensor JC-1. After 10 min of treatment with the mitochondrial membrane depolarizer carbonyl cyanide 3-chlorophenylhydrazone, 97
99% of cells lost red/green fluorescence associated with JC-1
accumulation in intact, polarized mitochondria (data not shown).
In like fashion, PMN mitochondrial membrane depolarization
occurred 60 min following phagocytosis of USA300 or RN6390,
with the greatest loss occurring in PMN fed USA300 (Fig. 1B).
Increased mitochondrial membrane depolarization in PMN fed
USA300 was confirmed using DIOC6 to assess mitochondrial
integrity (data not shown). Taken together, these data demonstrate
that intact PMN containing a population of viable USA300 exhibited some features typical of apoptosis, results consistent with
previous studies (7).
In general, increased expression of PS by apoptotic cells is
accompanied by a loss of dont eat me signals such as CD47 (17,
18). To determine if ingestion of USA300 altered expression of
dont eat me signals on PMN-SA, we compared the expression
of CD47 on PMN that were freshly isolated, aged, or fed opsonized
USA300. Surprisingly, although PMN-SA exhibited enhanced PS
exposure, PMN-SA challenged at an MOI of 1:1 expressed 1.3
7.2- and 1.31.7-fold higher levels of CD47 compared with Aged
PMN and PMN left alone in buffer, respectively (Fig. 1C, 1D).
There was 31% less CD47 on the surface of apoptotic PMN
compared with that on fresh PMN, but the decrease was not statistically significant (Fig. 1D). These data suggest that PMN-SA
exhibited an altered phenotype that was distinct from that typical
of apoptotic cells. Furthermore, the increased expression of CD47
on PMN-SA may influence their subsequent interactions with
macrophages, as loss of CD47 from the surface of apoptotic cells
inhibits SIRPa signaling and promotes efferocytosis (17, 18).
FIGURE 3. Macrophage cytokine production is skewed by PMN-SA. Human monocyte-derived macrophages were left alone (Mac), fed USA300 (SA) at
an MOI of 1:1, or fed PMN-SA at a ratio of five PMN-SA per macrophage or 15 PMN-SA per macrophage. Following a 6 h incubation, supernatants were
analyzed by Luminex or ELISA. Bars represent the mean of three individual experiments 6 SEM. Statistical analyses were performed using one-way
ANOVA and Tukey posttest. *p , 0.05 versus macrophages, #p , 0.05 versus macrophages + SA.
4713
4714
silica (Fig. 4B). The decreased IL-1b production reflected depressed NLRP3 engagement, as caspase-1 activation was less than
when macrophages were fed PMN-SA versus USA300 alone
(Fig. 4C). Taken together, these data indicate that PMN-SA elicited altered cytokine profiles in macrophages and failed to activate the NLRP3 inflammasome.
PMN-SA exhibit limited features of accelerated apoptosis
Because macrophages did not scavenge PMN-SA, we reasoned
that PMN lysis would be the predominant fate for PMN following ingesting of CA-MRSA. In fact, we and others (7, 9) had
demonstrated that PMN undergo lysis .180 min after phagocytosis of USA300, even at MOI as low as 1:1. Lysis requires viable
USA300 and is partially dependent on staphylococcal toxin production (7, 9, 23). Furthermore, PMN lysis late after ingestion of
USA300 is inhibited by pretreatment of PMN with inhibitors of
transcription or protein synthesis (7 and M.C. Greenlee-Wacker
and W.M. Nauseef, unpublished observations), demonstrating that
PMN actively engage endogenous responses that culminate in cell
disruption.
As demonstrated earlier (Fig. 1), PMN-SA initially exhibited
increased surface expression of PS and mitochondrial membrane
FIGURE 4. Inflammasome activation is dampened by PMN-SA. Human monocyte-derived macrophages (Mac) were treated with buffer or primed with
LPS for 2 h prior to treatment buffer alone, silica, USA300, or PMN-SA. Supernatants were analyzed for IL-1b production by Luminex for following a
6 or 12 h incubation (A) or by ELISA following a 6 h incubation (B). Caspase-1 cleavage was analyzed by immunoblotting following a 6 h incubation (C).
Bars represent the mean of five experiments 6 SEM (B) or three experiments (C). For (A), p values were determined using one-way ANOVA and Tukey
posttest. *p , 0.05 versus macrophages, ^p , 0.05 versus macrophages + SA. For (B), an outlier experiment was identified using Prism software
(GraphPad) and excluded from the analysis. p values were then determined using repeated-measures one-way ANOVA. *p , 0.05 versus macrophages +
LPS, #p , 0.05 versus macrophages + LPS + Silica, ^p , 0.05 versus macrophages + SA.
their potential to contribute to persistence or progression of infection during human disease. Based on these clinical observations
and experimental findings, we reasoned that the fate of PMN-SA
Discussion
Staphylococcal infections are generally characterized by resistance
to antimicrobial therapy, local persistence, distant metastases, and
tissue necrosis (28). Despite their important role in the innate
immune host response to invading microbes, PMN fail to kill and
degrade all ingested S. aureus that are trapped in phagosomes.
Furthermore, PMN-SA can transmit infection to naive mice or
rabbits in experimental models (29, 30), thereby demonstrating
depolarization, features characteristic of the initial stages of apoptosis. In contrast to apoptotic PMN, however, PMN-SA upregulated surface expression of CD47 and were not engulfed by
macrophages (Figs. 1, 2). These data suggest that PMN-SA may
derail the apoptotic cell death pathway. PCNA, a cell-cycle protein
expressed in PMN cytoplasm, promotes PMN survival by scavenging procaspases and thereby preventing their activation (24).
As decreased levels of cytoplasmic PCNA typically accompany
PMN apoptosis, we speculated that PMN-SA may increase PCNA
over time, sequester procaspases, and thereby contribute to prolonged survival. PCNA decreased and caspase-3 increased in
cultured PMN in a time-dependent fashion, results consistent with
the induction of apoptosis in normal PMN over time in culture
(Fig. 5A). In contrast, PMN-SA exhibited a sustained level of
PCNA compared with that of PMN in culture and cytoplasmic
PCNA was observed as late as 24 h following phagocytosis
(Fig. 5B). Furthermore, whereas anti-Fas Ab promoted caspase-3
activation in PMN, as previously demonstrated (25), PMN-SA
failed to activate caspase-3 with similar kinetics (Fig. 5). To determine if a higher MOI would induce caspase activation in
PMN, we challenged PMN with USA300 at an MOI of 10:1 and
assessed caspase activation (Fig. 6). Even at the higher MOI,
PMN fed USA300 failed to activate caspase-3 (Fig. 6A). In addition, PMN-SA failed to activate caspase-8, -9, and -2, whereas
opsonized beads or anti-FAS Ab prompted time-dependent increase in all caspases tested (Fig. 6BD). Taken together, the
sustained levels of cytoplasmic PCNA and the failure to activate
caspase-3 demonstrate a divergence of the phenotype of PMN-SA
from that typical for the apoptotic death pathway.
4715
4716
Acknowledgments
We thank Sarah Bloomberg, Michael Carlson (Beckman Coulter), Matthew
Long, Jamie Schwartz, and Dr. Mark White for excellent technical
assistance.
Disclosures
The authors have no financial conflicts of interest.
References
1. DeLeo, F. R., M. Otto, B. N. Kreiswirth, and H. F. Chambers. 2010.
Community-associated meticillin-resistant Staphylococcus aureus. Lancet
375: 15571568.
2. Rigby, K. M., and F. R. DeLeo. 2012. Neutrophils in innate host defense against
Staphylococcus aureus infections. Semin. Immunopathol. 34: 237259.
3. Nauseef, W. M. 2007. How human neutrophils kill and degrade microbes: an
integrated view. Immunol. Rev. 219: 88102.
4. Klebanoff, S. J., A. J. Kettle, H. Rosen, C. C. Winterbourn, and W. M. Nauseef.
2013. Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J. Leukoc. Biol. 93: 185198.
5. Voyich, J. M., K. R. Braughton, D. E. Sturdevant, A. R. Whitney, B. Sad-Salim,
S. F. Porcella, R. D. Long, D. W. Dorward, D. J. Gardner, B. N. Kreiswirth, et al.
2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175: 39073919.
6. Rogers, D. E., and R. Tompsett. 1952. The survival of staphylococci within
human leukocytes. J. Exp. Med. 95: 209230.
7. Kobayashi, S. D., K. R. Braughton, A. M. Palazzolo-Ballance, A. D. Kennedy,
E. Sampaio, E. Kristosturyan, A. R. Whitney, D. E. Sturdevant, D. W. Dorward,
S. M. Holland, et al. 2010. Rapid neutrophil destruction following phagocytosis
of Staphylococcus aureus. J. Innate Immun. 2: 560575.
8. Boles, B. R., M. Thoendel, A. J. Roth, and A. R. Horswill. 2010. Identification of
genes involved in polysaccharide-independent Staphylococcus aureus biofilm
formation. PLoS ONE 5: e10146.
9. Pang, Y. Y., J. Schwartz, M. Thoendel, L. W. Ackermann, A. R. Horswill, and
W. M. Nauseef. 2010. agr-Dependent interactions of Staphylococcus aureus
USA300 with human polymorphonuclear neutrophils. J. Innate Immun. 2: 546
559.
10. Nauseef, W. M. 2007. Isolation of human neutrophils from venous blood.
Methods Mol. Biol. 412: 1520.
11. Decleva, E., R. Menegazzi, S. Busetto, P. Patriarca, and P. Dri. 2006. Common
methodology is inadequate for studies on the microbicidal activity of neutrophils. J. Leukoc. Biol. 79: 8794.
12. Schwartz, J., K. G. Leidal, J. K. Femling, J. P. Weiss, and W. M. Nauseef. 2009.
Neutrophil bleaching of GFP-expressing staphylococci: probing the intraphagosomal fate of individual bacteria. J. Immunol. 183: 26322641.
26. He, S., L. Wang, L. Miao, T. Wang, F. Du, L. Zhao, and X. Wang. 2009. Receptor interacting protein kinase-3 determines cellular necrotic response to TNFalpha. Cell 137: 11001111.
27. Kaczmarek, A., P. Vandenabeele, and D. V. Krysko. 2013. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance.
Immunity 38: 209223.
28. DeLeo, F. R., and H. F. Chambers. 2009. Reemergence of antibiotic-resistant
Staphylococcus aureus in the genomics era. J. Clin. Invest. 119: 24642474.
29. Gresham, H. D., J. H. Lowrance, T. E. Caver, B. S. Wilson, A. L. Cheung, and
F. P. Lindberg. 2000. Survival of Staphylococcus aureus inside neutrophils
contributes to infection. J. Immunol. 164: 37133722.
30. Rogers, D. E. 1956. Studies on bacteriemia. I. Mechanisms relating to the persistence of bacteriemia in rabbits following the intravenous injection of staphylococci. J. Exp. Med. 103: 713742.
31. Brown, S., I. Heinisch, E. Ross, K. Shaw, C. D. Buckley, and J. Savill. 2002.
Apoptosis disables CD31-mediated cell detachment from phagocytes promoting
binding and engulfment. Nature 418: 200203.
32. Park, Y. J., G. Liu, Y. Tsuruta, E. Lorne, and E. Abraham. 2009. Participation of
the urokinase receptor in neutrophil efferocytosis. Blood 114: 860870.
33. Park, Y. J., G. Liu, E. F. Lorne, X. Zhao, J. Wang, Y. Tsuruta, J. Zmijewski, and
E. Abraham. 2008. PAI-1 inhibits neutrophil efferocytosis. Proc. Natl. Acad. Sci.
USA 105: 1178411789.
34. Hammond, M. E., G. R. Lapointe, P. H. Feucht, S. Hilt, C. A. Gallegos,
C. A. Gordon, M. A. Giedlin, G. Mullenbach, and P. Tekamp-Olson. 1995. IL-8
induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J.
Immunol. 155: 14281433.
35. Miller, L. S., R. M. OConnell, M. A. Gutierrez, E. M. Pietras, A. Shahangian,
C. E. Gross, A. Thirumala, A. L. Cheung, G. Cheng, and R. L. Modlin. 2006.
MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24: 7991.
36. Miller, L. S., E. M. Pietras, L. H. Uricchio, K. Hirano, S. Rao, H. Lin,
R. M. OConnell, Y. Iwakura, A. L. Cheung, G. Cheng, and R. L. Modlin. 2007.
Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J. Immunol. 179: 69336942.
37. Cho, J. S., Y. Guo, R. I. Ramos, F. Hebroni, S. B. Plaisier, C. Xuan, J. L. Granick,
H. Matsushima, A. Takashima, Y. Iwakura, et al. 2012. Neutrophil-derived IL-1b
is sufficient for abscess formation in immunity against Staphylococcus aureus in
mice. PLoS Pathog. 8: e1003047.
38. Feoktistova, M., P. Geserick, D. Panayotova-Dimitrova, and M. Leverkus. 2012.
Pick your poison: the Ripoptosome, a cell death platform regulating apoptosis
and necroptosis. Cell Cycle 11: 460467.
39. Vandenabeele, P., W. Declercq, F. Van Herreweghe, and T. Vanden Berghe. 2010.
The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci. Signal. 3:
re4.
40. Long, J. S., and K. M. Ryan. 2012. New frontiers in promoting tumour cell
death: targeting apoptosis, necroptosis and autophagy. Oncogene 31: 50455060.
4717